Skip to content

Investigation of the anti-inflammatory effects of heparin in mechanically ventilated patients

Evaluation the anti-inflammatory effects of nebulized heparin in ventilator-induced lung injury

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201701011497N6
Enrollment
60
Registered
2017-01-18
Start date
2015-07-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation. Other postprocedural respiratory disorders

Interventions

Intervention 1: Intervention group: Patients in drug group will receive heparin 10000 Iu every 6 hours via nebulization for 5 days. Both groups will receive all other standard treatments. Interventio
Treatment - Drugs
Intervention group: Patients in drug group will receive heparin 10000 Iu every 6 hours via nebulization for 5 days. Both groups will receive all other standard treatments
Control group: Patients will receive standard treatment.

Sponsors

Vice Chancellor for Research,Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who require invasive mechanical ventilation for more than 48 hours. Exclusion criteria:If patients receive mechanical ventilation for more than 24 hours prior to enrollment; has required mechanical ventilation for more than 48 hours in previous admission in ICU during the current hospital admission; allergy to heparin (including any history of heparin-induced thrombocytopenia); a pulmonary hemorrhage in the previous 3 months; uncontrolled bleeding or a significant bleeding disorder; an intracranial hemorrhage in the past 12 months; or an epidural catheter in place or likely to be placed in the next 48 hours and are younger than 18 years old.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Changes in ratio of partial pressure of oxygen to FiO2 (PaO2/FiO2). Timepoint: during the 5 days of study. Method of measurement: ratio of PaO2/FiO2.

Secondary

MeasureTime frame
(RSBI)RAPID SHALLOW BREATHING INDEX. Timepoint: during 5 days of study. Method of measurement: ratio of tidal volume to respiratory rate.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sarah Mousavi

Isfahan University of Medical Science

s.mousavi@pharm.mui.ac.ir+98 31 3792 7072

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026